Brewer, 2000, Recognition, diagnosis, and management of Wilson's disease, Proc Soc Exp Biol Mcd, 223, 19
Pandit, 2002, Wilson's disease, J Indian Pediatr, 69, 785, 10.1007/BF02723693
Tankanow, 1991, Pathophysiology and treatment of Wilson's disease, Clin Pharm, 10, 839
Yarsc, 1992, Wilson's disease: current status, Am I Med, 92, 643, 10.1016/0002-9343(92)90783-8
Lobene, 1986, A modified gingival index for use in clinical trials, Clin Prev Dent, 8, 3
Mombelli, 1987, The microbiota associated with successful or failing implants, Oral Microbiol Immunol, 2, 145, 10.1111/j.1399-302X.1987.tb00298.x
Newbrun, 1996, Indices to measure gingival bleeding, J Periodontol, 67, 555, 10.1902/jop.1996.67.6.555
Owen, 1976, Platelet function and coagulation in patients with wilson's disease, Arch Intem Med, 136, 148, 10.1001/archinte.1976.03630020010003
Frydman, 1985, Assignment of the gene for Wilson's disease to chromosome 13: linkage to the esterase D locus, Proc Natl Acad Sci USA, 82, 1819, 10.1073/pnas.82.6.1819
Brewer, 1994, Development of neurological symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine, Arch Neurol, 51, 304, 10.1001/archneur.1994.00540150106026
Brewer, 2003, Treatment of Wilson disease with ammonium tetrathiomolybdate III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy, Arch Neurol, 60, 379, 10.1001/archneur.60.3.379